Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Non-Current Deferred Tax Liability (2016 - 2023)

Historic Non-Current Deferred Tax Liability for Anika Therapeutics (ANIK) over the last 14 years, with Q3 2023 value amounting to $2.0 million.

  • Anika Therapeutics' Non-Current Deferred Tax Liability fell 7125.0% to $2.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $2.0 million, marking a year-over-year decrease of 7125.0%. This contributed to the annual value of $6.4 million for FY2022, which is 3663.48% down from last year.
  • Latest data reveals that Anika Therapeutics reported Non-Current Deferred Tax Liability of $2.0 million as of Q3 2023, which was down 7125.0% from $3.2 million recorded in Q2 2023.
  • Over the past 5 years, Anika Therapeutics' Non-Current Deferred Tax Liability peaked at $16.0 million during Q1 2020, and registered a low of $2.0 million during Q3 2023.
  • Over the past 5 years, Anika Therapeutics' median Non-Current Deferred Tax Liability value was $8.2 million (recorded in 2022), while the average stood at $8.4 million.
  • As far as peak fluctuations go, Anika Therapeutics' Non-Current Deferred Tax Liability skyrocketed by 37314.05% in 2020, and later tumbled by 7125.0% in 2023.
  • Over the past 5 years, Anika Therapeutics' Non-Current Deferred Tax Liability (Quarter) stood at $4.3 million in 2019, then surged by 174.65% to $11.9 million in 2020, then fell by 14.61% to $10.2 million in 2021, then crashed by 36.63% to $6.4 million in 2022, then crashed by 69.62% to $2.0 million in 2023.
  • Its Non-Current Deferred Tax Liability stands at $2.0 million for Q3 2023, versus $3.2 million for Q2 2023 and $4.1 million for Q1 2023.